False-positive recalls in the prospective Malmö Breast Tomosynthesis Screening Trial - Takeaways - MDSpire

False-positive recalls in the prospective Malmö Breast Tomosynthesis Screening Trial

  • By

  • Kristin Johnson

  • Jakob Olinder

  • Aldana Rosso

  • Ingvar Andersson

  • Kristina Lång

  • Sophia Zackrisson

  • May 5, 2023

  • 0 min

Share

  • 1

    Digital breast tomosynthesis (DBT) may replace or complement digital mammography (DM) in breast cancer screening.

  • 2

    False-positive recalls in breast cancer screening can cause psychosocial distress and reduce future screening attendance.

  • 3

    The Malmö Breast Tomosynthesis Screening Trial (MBTST) compared one-view DBT with two-view DM in a population-based screening trial.

  • 4

    In the MBTST, the false-positive recall rate was initially higher for DBT compared to DM, primarily due to stellate distortions.

  • 5

    The study evaluated false-positive recalls, appearances, and outcomes over the trial years to provide insights into DBT's early clinical experiences.

Original Source(s)

Related Content